Showing posts with the label moderateShow all
October 11, 2021
Risk of dangerous blood clots linked to moderate COVID-19; high-dose blood thinner can prevent clots
A medical employee takes a blood pattern from a saleswoman throughout a voluntary fast antigen testing marketing campa…
Read more
October 08, 2021
Two Indian drugmakers seek to end Merck's molnupiravir trials for moderate COVID-19
An experimental COVID-19 therapy tablet known as molnupiravir being developed by Merck & Co Inc and Ridgeback Biot…
Read more